Status:
COMPLETED
Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III
Lead Sponsor:
SK Chemicals Co., Ltd.
Collaborating Sponsors:
Korea University Anam Hospital
Conditions:
Healthy
Eligibility:
MALE
19-40 years
Phase:
PHASE1
Brief Summary
To evaluate the PK/PD of single injected human ATIII Products, SKATIII and ATIII, phase1 study in healthy male subjects was designed
Eligibility Criteria
Inclusion
- ages 19 to 40
- Body weight: More than 50kg
- Healthy male subject
Exclusion
- Hb\<14g/dL, Hct\<42%
- ATIII hypersensitivity
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00846274
Start Date
October 1 2008
End Date
December 1 2008
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SK chemicals
Seoul, South Korea